EGFR-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?

SIMPLE SUMMARY: Tyrosine kinase inhibitors are drugs targeting the epidermal growth factor receptor. In lung cancer, they are used to treat advanced EGFR-mutant diseases, and more recently, one has been approved for adjuvant therapy. Even though publications on the topic are numerous, conclusions ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Cansouline, Xavier, Lipan, Béatrice, Sizaret, Damien, Tallet, Anne, Vandier, Christophe, Carmier, Delphine, Legras, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099844/
https://www.ncbi.nlm.nih.gov/pubmed/35565386
http://dx.doi.org/10.3390/cancers14092257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099844/
https://www.ncbi.nlm.nih.gov/pubmed/35565386
http://dx.doi.org/10.3390/cancers14092257

Ejemplares similares